Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 4, 2004 - Issue 1
Submit an article Journal homepage
27
Views
2
CrossRef citations to date
0
Altmetric
Review

Pharmacoeconomic review of recombinant human DNase in the management of cystic fibrosis

Gerrit S Zijlstra Groningen University Institute for Drug Exploration, Pharmaceutical Technology and Biopharmacy, University of Groningen Research Institute of Pharmacy, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. [email protected]
,
Cornelis Boersma Groningen University Institute for Drug Exploration, Pharmacoepidemiology and Drug Policy, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. [email protected]
,
Henderik W Frijlink Groningen University Institute for Drug Exploration, University of Groningen Research Institute of Pharmacy, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. [email protected]
&
Maarten J Postma Groningen University Institute for Drug Exploration, University of Groningen Research Institute of Pharmacy, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. [email protected]
Pages 49-59 | Published online: 09 Jan 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gerrit S. Zijlstra, Bart J. Ponsioen, Sylvia A. Hummel, Niek Sanders, Wouter L.J. Hinrichs, Anne H. de Boer & Henderik W. Frijlink. (2009) Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation. Pharmaceutical Development and Technology 14:4, pages 358-368.
Read now
Steven P Conway, Daniel G Peckham, Miles Denton & Keith, G Brownlee. (2005) Optimizing treatment policies and improving care: impact on outcome in patients with cystic fibrosis. Expert Review of Pharmacoeconomics & Outcomes Research 5:6, pages 791-806.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.